ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QuadLock(TM), its new ...
ABANZA’s QuadLock™ delivers market-leading fixation strength with over a 500% reduction in cyclic displacement compared to conventional fixation methods. QuadLock™ is designed to securely fixate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results